NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 231 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,282,644 | +203.5% | 118,764 | +301.4% | 0.01% | +100.0% |
| Q2 2023 | $752,051 | -80.5% | 29,585 | -72.2% | 0.00% | -94.8% |
| Q1 2023 | $3,849,830 | +279.9% | 106,496 | +316.2% | 0.06% | +222.2% |
| Q4 2022 | $1,013,285 | +273.9% | 25,588 | +339.7% | 0.02% | +260.0% |
| Q3 2022 | $271,000 | -71.0% | 5,819 | -72.7% | 0.01% | -80.8% |
| Q2 2022 | $933,000 | +46.0% | 21,291 | +140.9% | 0.03% | +52.9% |
| Q1 2022 | $639,000 | -37.5% | 8,838 | -29.9% | 0.02% | -46.9% |
| Q4 2021 | $1,022,000 | +129.1% | 12,609 | +229.4% | 0.03% | +146.2% |
| Q3 2021 | $446,000 | +89.0% | 3,828 | +125.6% | 0.01% | -50.0% |
| Q3 2020 | $236,000 | -36.4% | 1,697 | -60.6% | 0.03% | +13.0% |
| Q3 2019 | $371,000 | -10.8% | 4,310 | -32.9% | 0.02% | -50.0% |
| Q2 2019 | $416,000 | +96.2% | 6,420 | +72.8% | 0.05% | -53.5% |
| Q3 2018 | $212,000 | – | 3,716 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,192,298 | $47,215,001 | 1.58% |
| Altium Capital Management LP | 76,000 | $3,009,600 | 1.53% |
| Rock Springs Capital Management LP | 1,077,900 | $42,684,840 | 1.03% |
| Integral Health Asset Management, LLC | 109,000 | $4,316,400 | 0.91% |
| ArrowMark Colorado Holdings LLC | 1,252,218 | $49,587,833 | 0.59% |
| FOX RUN MANAGEMENT, L.L.C. | 26,963 | $1,067,735 | 0.43% |
| PDT Partners, LLC | 55,715 | $2,206,314 | 0.36% |
| FRED ALGER MANAGEMENT, LLC | 1,184,000 | $46,886,400 | 0.25% |
| Dynamic Technology Lab Private Ltd | 62,819 | $2,488 | 0.25% |
| K2 PRINCIPAL FUND, L.P. | 38,000 | $1,504,800 | 0.23% |